C12N 2770/12071
Demonstrated in vivo effect
C12N2770/12071 (Demonstrated in vivo effect) appears on 5 US grants and 7 published applications in this corpus.
Search patents in C12N- Granted patents
- 5
- Published applications
- 7
- Assignees
- 4
- Inventors
- 2
- Latest grant
- 13 May 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2016 | 0 | 1 |
| 2017 | 0 | 0 |
| 2018 | 1 | 0 |
| 2019 | 0 | 2 |
| 2020 | 0 | 1 |
| 2021 | 2 | 1 |
| 2022 | 0 | 0 |
| 2023 | 1 | 0 |
| 2024 | 0 | 1 |
| 2025 | 1 | 0 |
| 2026 | 0 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Synthetic peptide compounds and methods of use13 May 2025US 12,297,235 B2Realta Holdings, LLC
- Synthetic peptide compounds and methods of use14 Nov 2023US 11,814,414 B2Realta Holdings, LLC
- Synthetic peptide compounds and methods of use16 Mar 2021US 10,947,279 B2Realta Holdings, LLC
- Synthetic peptide compounds and methods of use2 Mar 2021US 10,933,116 B2Realta Holdings, LLC
- Derivative peptide compounds and methods of use26 Jun 2018US 10,005,818 B2Realta Holdings, LLC
- Synthetic peptide compounds and methods of use14 May 2026US 2026/0132170 A1Realta Holdings, LLC
- Synthetic peptide compounds and methods of use29 Feb 2024US 2024/0067680 A1Realta Holdings, LLC
- Synthetic peptide compounds and methods of use3 Jun 2021US 2021/0163543 A1Realta Holdings, LLC
- Synthetic peptide compounds and methods of use13 Aug 2020US 2020/0254053 A1Children's Health Foundation, Inc.
- Synthetic peptide compounds and methods of use22 Aug 2019US 2019/0256561 A1Realta Holdings, LLC
Most cited
By later US patents